Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients
Overactive BladderUro-Oncology
Related content
Overactive BladderUro-Oncology
Propensity matched comparative analysis of survival following chemoradiation or radical cystectomy for muscle-invasive bladder cancer
BJU Int
Ritch CR, Balise R, Prakash NS, Alonzo D, Almengo K, Alameddine M, Venkatramani V, Punnen S, Parekh DJ, Gonzalgo ML
doi: 10.1111/bju.14109.
RECOMMENDED
Uro-Oncology
Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies
★ 2
Recommended by
Prof. Dr Richard Cathomas, Faculty Member
Eur Urol.
Necchi A, Raggi D, Gallina A, Madison R, Colecchia M, Lucianò R, Montironi R, Giannatempo P, Farè E, Pederzoli F, Bandini M, Bianchi M, Colombo R, Gandaglia G, Fossati N, Marandino L, Capitanio U, Dehò F, Ali SM, Chung JH, Ross JS, Salonia A, Briganti A, Montorsi F
doi: 10.1016/j.eururo.2019.10.026.
Uro-Oncology
The prognostic impact of hexaminolevulinate-based bladder tumor resection in patients with primary non-muscle invasive bladder cancer treated with radical cystectomy
World J Urol.
Renninger M, Fahmy O, Schubert T, Schmid MA, Hassan F, Stenzl A, Gakis G
doi: 10.1007/s00345-019-02780-0.
Overactive BladderUro-Oncology
Detection and Clinical Significance of Circulating Tumor Cells in Patients Undergoing Radical Cystectomy for Urothelial Bladder Cancer
Clin Genitourin Cancer.
Pagliarulo V, Ancona P, Petitti T, Salerno A, Spadavecchia R, Di Stasi S, Cormio L, Maurizio B, Carrieri G, Ditonno P
doi: 10.1016/j.clgc.2016.11.005.
Uro-Oncology
A Systematic Review and Meta-analysis of Variant Histology in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy
J Urol.
Mori K, Abufaraj M, Mostafaei H, Quhal F, Karakiewicz PI, Briganti A, Kimura S, Egawa S, Shariat SF
doi: 10.1097/JU.0000000000001305.
Uro-Oncology
The Cancer of the Bladder Risk Assessment (COBRA) score for Estimating Cancer-Specific Survival after Radical Cystectomy: External Validation in a Large Bi-institutional Cohort
BJU Int.
Muilwijk T, Akand M, Soria F, Giordano A, Milenkovic U, Moris L, Gevaert T, Van Poppel H, Albersen M, Gontero P, Joniau S
doi: 10.1111/bju.15163.
Uro-Oncology
Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial
Eur Urol.
Briganti A, Gandaglia G, Scuderi S, Gallina A, Colombo R, Fossati N, Barletta F, Pellegrino A, Nocera L, Montorsi F, Necchi A
doi: 10.1016/j.eururo.2019.12.019.
Uro-Oncology
No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study
World J Urol.
Jerlström T, Chen R, Liedberg F, Andrén O, Ströck V, Aljabery FAS, Hosseini A, Sherif A, Malmström PU, Ullén A, Gårdmark T, Fall K
doi: 10.1007/s00345-019-02770-2
Overactive BladderUro-Oncology
Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy
J Urol
Martini A, Afferi L, Zamboni S, Schultz JG, Lonati C, Mattei A, Karnes RJ, Soligo M, Stabile A, Di Trapani E, De Cobelli O, Simone G, Simeone C, Alvarez-Maestro M, Gandaglia G, Gallina A, Colombo R, Briganti A, Montorsi F, Xylinas E, Shariat SF, Moschini M
doi: 10.1097/JU.0000000000001886